NPC

The MeDiPro Anti-EBV IgA ELISA is an enzyme linked immunosorbent assay intended for the quantitative detection of human IgA antibodies to the early antigen and nuclear antigen of the Epstein-Barr virus contained in human serum or plasma. Results are obtained in 2 hours. This product is designed for differentiating nasopharyngeal carcinoma patients from normal population and suit for mass screening. The specificity and sensitivity are both above 95%.

1.Use genetic engineered EBV-associated proteins as antigens.

2.An ELISA test for detection of anti-(EBV EA+EBNA-1) IgA.

3.With greater than 95% of specificity and sensitivity.

4.Easy in assay procedure and result to interpretation.

5.Quantitative determination or qualitative with Immune Status Ratio is available.

6.Suitable for early screens diagnosis and prognosis of naspharynglal carcinoma.